Skip to main content
Download PDF

Antiproliferative activity of marine stingray Dasyatis sephen venom on human cervical carcinoma cell line

Journal of Venomous Animals and Toxins including Tropical Diseases volume 21, Article number: 41 (2015) Cite this article

Abstract

Background

Venoms comprise mixtures of numerous bioactive compounds that have a wide range of pharmacologic actions. Toxins from venomous animals have attracted the attention of researchers because of their affinity for primary sites responsible for lethality and their efficacy at extremely low concentrations. The venoms of marine stingrays have not been extensively studied and limited data is available on them. The present study aims to evaluate the antiproliferative and biochemical properties of the venom obtained from a species of marine stingray (Dasyatis sephen) on human cervical cancer cell line HeLa.

Methods

The antiproliferative effect of D. sephen venom was determined by MTT assay, and the oxidative stress was determined by lipid peroxidation method along with assessment of changes in the enzymatic and non-enzymatic antioxidant status. We observed intracellular reactive oxygen species (ROS) levels by DCFH-DA method, mitochondrial membrane potential alterations by rhodamine 123 staining and apoptotic morphological changes by acridine orange/ethidium bromide dual staining method.

Results

D. sephen venom enhances lipid peroxidative markers such as thiobarbituric acid reactive substance, conjugated diene, and lipid hydroperoxide in HeLa cell lines. Stingray venom enhances the ROS levels, which is evidenced by the increased 2–7-diacetyl dichlorofluorescein fluorescence. Further, D. sephen venom treatment altered the mitochondrial membrane potential in HeLa cells. Additionally, we observed increased apoptotic morphological changes in D. sephen venom-treated groups.

Conclusions

Dasyatis sephen venom exhibits potent antiproliferative effect on HeLa cell line and upon further purification it could be a promising antiproliferative agent.

Background

Marine organisms comprise approximately one-half of the total global biodiversity; therefore, they offer an important source for novel compounds that has been classified as the largest reservoir of natural molecules to be evaluated for drug activity [1]. A different type of environment exists in the ocean, where organisms live in competitive and aggressive surroundings that differ in many aspects from the terrestrial environment. This competitive environment demands the production of quite specific and potent active molecules by marine organisms [2]. These organisms have been continuously screened for pharmacologically active substances and till date over 6500 marine natural products have been isolated [3].

Cancer is characterized by the uncontrolled growth and spreading of abnormal cells. In normal cell function and tissue homeostasis, proliferation and apoptosis are balanced. Cancer cells display abnormal in vivo proliferation that is not balanced by compensatory apoptosis [4]. Apoptosis, defined as a controlled form of cell death, might represent a pivotal point in cancer treatment development [5]. For the past few decades, venom components have become the focus of researchers and have been extensively studied for their various anticancer properties with effective inhibition of proliferation. The anticancer potential of venom on adenocarcinoma cells was first reported for Naja snake venoms by Calmette et al. [6]. In addition, bee venom has also proven to have antiproliferative activity in vitro and ability to reduce tumor growth in vivo [7]. Scorpion venom toxins demonstrate antiproliferative activity against human glioma and leukemic cells as well [8, 9]. Marine environment is highly diverse and several compounds from marine origin have been approved for clinical use, including vidarabine (recurrent epithelial keratitis and superficial keratitis), cytarabine (cancer), ziconotide (chronic pain in cancer or AIDS), trabectedin (soft tissue sarcoma) and halaven (metastatic breast cancer) [10, 11]. But, concerning fish venoms, limited data are available about their bioactive potential.

Marine stingrays are venomous fish of the Elasmobranch family and are mainly found in temperate and tropical areas of the world. Stingrays are considered to be one of the most significant venomous fish in the world [12]. They have serrated spines at the base of the tail that penetrate the body of the victim. The epidermal covering of the spine releases venom into the sting site causing severe pain and tissue necrosis [13]. Stingray venom exhibits neurotoxic, cardiotoxic, fibrinogenolytic and anticoagulant activities and are composed of proteins, serotoxin, vasoconstrictor peptides and several other unidentified components [14–18]. In this study, the mechanism by which the venom of the marine stingray D. sephen inhibits cell proliferation and the associated apoptotic pathways are examined in human cervical cancer cells (HeLa).

Methods

Chemicals

Bovine serum albumin, thiobarbituric acid (TBA), phenazine methosulphate (PMS), nitroblue tetrazolium (NBT), 5,5-dithiobis(2-nitrobenzoic acid) (DTNB), 3-(4,5-dimethyl-2-thiaozolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT), 2–7-diacetyl dichlorofluorescein (DCFH-DH), rhodamine 123 (Rh-123), acridine orange, ethidium bromide, heat inactivated fetal calf serum (FCS), minimum essential medium (MEM), McCoy’s modified medium, glutamine, penicillin-streptomycin, EDTA and trypsin were purchased from Sigma Chemicals Co. (USA).

Venom extraction

Stingray specimens were collected from Parangipettai coast (11°30’1.19“N 79°46’20.50”E, Tamil Nadu, India) by local fishermen. The spines that are usually discarded by fishermen due to the lack of commercial value were removed from the base of the tail and transported to the laboratory in an icebox. The tissue covering the stingers was scratched and homogenized in PBS buffer, pH 7.4 and centrifuged at 5000 × g for 10 min. The supernatant (venom) was stored at − 20 °C until use [19]. Protein concentration of the supernatant was estimated by standard method using BSA as protein standard. Details about the D. sephen and stinger images are provided in Additional file 1.

Cell lines and culture conditions

The present work was carried out on human cervical cancer cell line (HeLa). The cell line was obtained from the National Centre for Cell Science (NCCS), Pune, India. HeLa cells were grown as monolayer in MEM medium supplemented with 10 % FCS, 2mM glutamine, and 100 U/mL penicillin-streptomycin at 37 °C in 5 % CO2 atmosphere. Stocks were maintained in 25 cm2 tissue culture flasks.

Study group and dose fixation study

Cells were treated with different concentrations of stingray venom (2, 4, 8, 12, 16, 20 or 24 μg/mL) and the cytotoxicity was observed by MTT assay. PBS used as a sham control. The results assessed by MTT assay were employed in further experiments in which five groups were defined based on the venom administration doses:

  • Group I: untreated HeLa cells (control)

  • Group II: HeLa cells + D. sephen venom (4 μg/mL)

  • Group III: HeLa cells + D. sephen venom (8 μg/mL)

  • Group IV: HeLa cells + D. sephen venom (12 μg/mL)

  • Group V: HeLa cells + D. sephen venom (16 μg/mL)

Drug sensitivity assay

The growth inhibitory activity of cells was determined by the MTT assay based on the detection of mitochondrial dehydrogenase activity in living cells [20]. Each culture well was incubated for 24 h with different doses of D. sephen venom. Ten microliters of MTT solution (5 mg/mL in PBS) was added and incubated for 4 h to allow color development. An equal volume of DMSO was then added to stop the reaction and to solubilize the blue crystals formed. The absorbance was taken at the wavelength of 570 nm.

Measurement of intracellular ROS in cells by spectrofluorimetric and fluorescence microscopic methods

Intracellular ROS was measured by using a nonfluorescent probe, DCFH-DA, which penetrates into the intracellular matrix of cells to be oxidized by ROS to fluorescent dichlorofluorescein (DCF) [21]. Cells were incubated for 24 h with different concentrations of D. sephen venom. Fluorescent dye DCFH-DA was then added to the cells and incubated for 30 min. The cells were washed with PBS to remove the excess dye before fluorescent measurements that were carried out with excitation and emission filters set at 485 ± 10 and 530 ± 12.5 nm, respectively (Shimadzu RF-5301 PC Spectrofluorometer, Japan). Fluorescence microscopic images were taken using blue filter (450–490 nm) (Nikon, Eclipse TS100, Japan).

Alterations in mitochondrial membrane potential

After cell incubation with D. sephen venom for 24 h, fluorescent dye Rh-123 (10 μg/mL) was added to the cells. The cells were then incubated for 30 min, washed with PBS and analyzed in fluorescence microscope using blue filter [21]. Polarized mitochondria were marked by orange-red fluorescence, and depolarized mitochondria were marked by green fluorescence.

Apoptotic morphological changes by acridine orange-ethidium bromide dual staining method

Staining of DNA with acridine orange (AO) and ethidium bromide (EBr) allowed visualization of the condensed chromatin of dead apoptotic cells [21]. Stained cells were viewed under a fluorescence microscope. The number of cells showing features of apoptosis was counted as a function of the total number of cells present in the field.

Estimation of lipid peroxidation markers

The cells were harvested by trypsinization. The pellet obtained was suspended in PBS and taken for the measurement of lipid peroxidative markers such as thiobarbituric acid reactive substances (TBARS), conjugated dines (CD), and lipid hydro peroxide (LHP), according to the procedures described elsewhere [22–24].

Estimation of antioxidant enzyme activity

The supernatant obtained after centrifuging the trypsinized cells was used for the measurement of activities of antioxidant enzymes, superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx), according to the procedures described elsewhere [25–27]

Estimation of reduced glutathione levels

The levels of reduced glutathione (GSH) were determined in the supernatant obtained after centrifuging the trypsinized cells according to the procedures described elsewhere [28].

Statistical analysis

Statistical analysis was performed using one way analysis of variance (ANOVA) followed by Duncan’s multiple range test (DMRT) by using Statistical Package of Social Science (SPSS) version 12.0 for Windows. The values were expressed as mean ± SD for six samples in each group. In addition, p value of < 0.05 was considered as statistically significant.

Results

Effect of D. sephen venom on cell proliferation

Effect of D. sephen venom on cell proliferation was determined by MTT assay. The proliferation of HeLa cells was significantly inhibited by D. sephenvenom. Figure 1 shows the changes in the percentage of cell death in control and venom-treated cells. The treatment with 2 μg/mL of D. sephen venom did not show significant (p < 0.05) proliferation inhibition. The treatment with 4, 8, 12 and 16 μg/mL of D. sephen venom significantly inhibited in HeLa cells. Concentrations of 16 and 20 μg/mL displayed almost the same inhibitory effect (80 and 81 % inhibition) on HeLa cells. Hence, for further tests D. sephen venom concentrations of 4, 8, 12 and 16 μg/mL were used on HeLa cells.

Fig. 1
figure 1

Cytotoxicity of D. sephen venom on HeLa cells. The venom was incubated with cancer cells for 24 h and cytotoxicity was observed by MTT assay. Cell death was observed in a concentration-dependent manner (2–20 μg/mL) in HeLa cells. Values were given as mean ± SD of six experiments in each group. Values not sharing the same letter differ significantly (p < 0.05) from control (DMRT)

Full size image

D. sephen venom generates intracellular ROS

Levels of ROS in control and D. sephen venom-treated cells are depicted in Fig. 2 – A (i) and B (i). Venom treatment significantly increased ROS level in HeLa cells. Venom concentrations of 4, 8, 12, and 16 μg/mL increased ROS levels to 12, 30, 63 and 75 %, respectively, when compared to control group. Among all tested doses, 16 μg/mL showed maximum generation of ROS in HeLa cells.

Fig. 2
figure 2

a Photomicrographs show the effect of D. sephen venom on: (i) intracellular ROS generation; (ii) mitochondrial membrane potential and; (iii) apoptotic morphology changes in HeLa cells. b Effect of D. sephen venom on: (i) intracellular ROS generation; (ii) mitochondrial membrane potential and; (iii) percentage of apoptosis in HeLa cells. Values were given as mean ± SD of six experiments in each group. Bars not sharing a common letter differ significantly (p < 0.05) from control (DMRT)

Full size image

D. sephen venom modulates mitochondrial membrane potential

Changes in mitochondrial membrane potential in control and D. sephen venom-treated cells are depicted in Fig. 2 – A (ii) and B (ii). D. sephen venom treatment significantly increased mitochondrial depolarization in HeLa cells. After 24-hour incubation, venom treated cells showed significantly decreased mitochondrial membrane potential to 57, 35, 18, and 10 % at 4, 8, 12, and 16 μg/mL concentrations of D. sephen venom in HeLa cells, respectively, when compared to control group. Among all the doses tested, 16 μg/mL of D. sephen venom showed the highest level of mitochondrial depolarization in HeLa cells. Polarized mitochondria were marked by orange-red fluorescence and depolarized mitochondria were marked by green fluorescence.

Effect of D. sephen venom on apoptotic morphological changes

Figure 2 – A (iii) and B (iii) show the effect of D. sephen venom on apoptotic morphological changes. Figure 2 – A (iii) shows the fluorescence microscopic observation of the untreated and treated cancer cells. Untreated cancer cells appeared in green (AO stained) whereas venom treated cells appeared in red/orange (EtBr stained) that revealed the presence of apoptotic cells. Figure 2 – B (iii) shows the percentage of apoptosis. Venom concentrations of 4, 8, 12, and 16 μg/mL increased apoptotic cells levels to 30, 50, 74 and 78 %, respectively, when compared to the control group. Among all the doses tested, 16 μg/mL of D. sephen venom showed increased apoptotic levels in HeLa cells.

Changes in the levels of lipid peroxidative markers and the activities of enzymatic antioxidants

We observed the levels of lipid peroxidative markers, such as TBARS, CD and LHP in control and venom-treated cells (Fig. 3). D. sephen venom treatment increased the levels of lipid peroxidation in Hela cells. Among all the concentrations (4, 8, 12, and 16 μg/mL) tested, 16 μg/mL significantly increased levels of TBARS, CD and LHP in HeLa cells.

Fig. 3
figure 3

Effect of D. sephen venom on lipid peroxidation in HeLa cells. Bars represent the changes on the levels of lipid peroxidative markers (TBARS, CD and LPH) in HeLa cells. Values were given as mean ± SD of six experiments in each group. Values not sharing the same letter differ significantly (p < 0.05) from control (DMRT)

Full size image

Activities of enzymatic antioxidants such as SOD, CAT, and GPxare are depicted in Fig. 4. D. sephen venom (4, 8, 12, and 16 μg/mL) treatment significantly decreased the activities of SOD, CAT, and GPx in HeLa cells. Among all tested doses, 16 μg/mL of D. sephen venom significantly decreased enzymatic activities when compared with other doses in HeLa cells. In this study, the effect of D. sephen venom on glutathione levels in venom-treated cancer cells was examined. Levels of GSH in control and venom-treated cells are showed in Fig. 5. The treatment of D. sephen venom (4, 8, 12, and 16 μg/mL) decreased GSH levels in HeLa cells. Regarding all the doses tested, 16 μg/mL of D. sephen venom significantly decreased GSH levels in HeLa cells.

Fig. 4
figure 4

Effect of D. sephen venom on cellular antioxidant status in HeLa cells. Bars represent the changes on the activities of SOD, CAT and GPx in control and venom treated cells. *Enzyme concentration required for 50 % inhibition of nitroblue tetrazolium reduction in one minute. **μmol of hydrogen peroxide consumed per minute. ***μg of glutathione consumed per minute

Full size image
Fig. 5
figure 5

Effect of D. sephen venom on reduced GSH levels in HeLa cells. Treated cells were incubated for 24 h at 37 °C and then reduced GSH levels were measured in cell lysate. Values were given as mean ± SD of six experiments in each group. Values not sharing the same letter differ significantly (p < 0.05) from control (DMRT)

Full size image

Discussion

Venoms from many marine sources have demonstrated to be highly effective in low concentrations. Marine fish venoms have not been fully explored and their biological potentials have not been completely characterized. In the present study, we evaluated in vitro antiproliferative potential of stingray venom extracts on HeLa cell line. D. sephen venom venom significantly decreased the viability of cancer cells. There was a significant increase in cytotoxicity (26, 42, 68 and 80 %) of HeLa cells with increasing concentrations of this venom at 4, 8, 12, and 16 μg/mL, respectively. Our results indicate that concentrations of the compounds play a vital role in cytotoxicity. It is very likely that D. sephen venom may disrupt mitochondrial dehydrogenase activity of cancer cells at higher concentrations [29]. Mitogenic and cytotoxic effects of venom from marine sources such as S. verrucosa and H. rubripinnis on regular and tumor cell lines have been reported earlier [30]. However, the molecular role of venom in disrupting intracellular signaling pathways leading to apoptosis (programed cell death) of cancer cells have not yet been elucidated [31]. Fleury et al. [32] stated that an increase in the production of ROS associated with disturbance in the oxidative status results in the impairment of mitochondrial function that triggers the apoptosis pathway. Hence, in this study, assessment of ROS species, mitochondrial function and antioxidant enzyme activity determination was carried out.

ROS is known to be generated intracellularly though three pathways: as the byproduct of normal aerobic metabolism; as second messengers in various signal transduction pathways; and in response to environmental stress. Depending upon the concentration, ROS is known to elicit a wide spectrum of biological responses ranging from mitogenic to proliferative effects at low concentrations, and macromolecular damage leading to cell death at high concentrations [33]. Previous reports have suggested that Okinawa habu apoxin protein-1 (OHAP-1) from Okinawa habu (T. flavovirudis) venom induced apoptosis in malignant glioma cell lines by promoting the generation of intracellular ROS [34]. Similarly, in our study D. sephen venom caused a rapid increase of intracellular ROS levels (63 and 76 % at 12 and 16 μg/mL concentrations, respectively) in HeLa cells after 24 h of incubation.

ROS are known to be generated from the reaction of leaked electrons with oxygen under various systems including lipid peroxidation. Lipid peroxidation is a multistep process in which the initially formed lipid radicals are converted to TBRS via the unstable intermediate products CD and LPH [35]. We observed the levels of lipid peroxidative products, such as TBARS, CD and LHP in control and D. sephen venom-treated cells. D. sephen venom treatment increased the levels of lipid peroxidative products in HeLa cells. Among all the concentrations tested (4, 8, 12, and 16 μg/mL), 16 μg/mL of venom showed significantly increased levels of TBARS, CD and LHP in HeLa cells.

Mitochondrion is one of the most important organelles that regulate cell death and mark apoptosis [36]. Functional alterations of mitochondria have been shown to play an important role in cell apoptosis [37]. The mitochondria of normal cells pump H+ from initial ground substance to the outside of the endomembrane creating a transmembrane potential. In the present study, mitochondria membrane potential was calculated in order to examine whether apoptosis is accompanied by the loss of mitochondrial transmembrane potential. We observed D. sephen venom-treated cells showed significantly decreased mitochondrial membrane potential by 57, 35, 18, and 10 % at concentrations of 4, 8, 12, and 16 μg/mL, respectively, in HeLa cells when compared to the control group. Rh-123, a mitochondria-specific membrane permeable dye, was accumulated in the mitochondria of control cells whereas venom-treated cells exhibited decreased uptake of it with increasing concentrations. Our results indicate that the mithochondrial damage occurred during D. sephen venom treatment, which suggests that the alteration of mitochondrial membrane potential (MMP) may have a role in venom-induced cell death. HeLa cell death induced by venom might be due to mitochondrial toxicity, as the MMP collapsed before apoptosis. This observation corroborates a previous study in which treatment with the O. doriae venom induced reactive nitrogen intermediates, caspase 3 and depolarization in mitochondria [38].

Apoptosis plays an important role in determining cellular cytotoxicity following drug treatment [39]. It is known to be associated with a characteristic set of morphological features, including membrane blabbing, chromosomal condensation, nuclear fragmentation, cell shrinkage and formation of apoptotic bodies. In the present study, we observed that D. sephen venom pretreatment significantly increased morphological changes associated in HeLa cells leading to 74 to 78 % of apoptosis at concentrations of 12 to 16 μg/mL. Fluorescence microscopic observation of the cells showed a typical apoptotic morphology – cell pyknosis, chromosome condensation and nuclear fragmentation in D. sephen venom-treated cells when stained with EtBr/AO.

Acridine orange (AO) is a cationic dye known to penetrate the intact membrane of living cells and stain DNA. On the other hand, EtBr is not incorporated by live cells. Hence, control cells can be observed as green under blue emission. On the contrary, cells undergoing apoptosis are not able to exclude EtBr and then exhibit more intense red color [40]. Increased ROS levels and loss of mitochondrial membrane potential might be the reason for increased apoptotic morphological changes such as cell pyknosis and chromosome condensation observed in the venom-treated cells.

In our body, antioxidant enzymatic defense is a very important tool to neutralize oxygen free radical-mediated tissue injury [41]. Free radical scavenging enzymes such as CAT, SOD, and GPx are the first line of cellular defense against oxidative injury, decomposing O2 and H2O2 before their interaction to form the more reactive hydroxyl radical. Antioxidant enzymes can antagonize initiation and promotion phases of carcinogenesis and their levels are reduced in many malignancies [42]. Cell malignancy or transformation is often accompanied by decrease in activity of antioxidant enzymes like CAT, SOD, and GPx, which increases the cell sensitivity to prooxidant compounds [43]. D. sephen venom at concentrations of 4, 8, 12, and 16 μg/mL significantly decreased the activities of SOD, CAT, and GPx in HeLa cells. Among all the doses tested, 16 μg/mL expressively decreased enzymatic activities when compared with other doses in HeLa cells. It has been shown in the literature that anticancer agents deplete intracellular antioxidants and because of that, there is increased accumulation of free radicals inside the cells which modulate the opening of the mitochondrial permeability transition pore resulting in apoptosis [21, 35]. The present finding indicates that the D. sephen venom has caused cell death by damaging mitochondria, increasing intracellular ROS formation and depletion of cellular antioxidant enzyme in a dose-dependent manner in HeLa cells. This corroborates a previous study that showed the cytotoxic potential of Conus vexillum venom, which induced oxidative stress [44].

GSH plays a key role in protecting cells from electrophilic compounds and free radicals generated during cellular metabolism. Depletion of GSH can lead to tumor cell death in vitro, especially in melanocytic cells that generate high levels of oxyradicals [45, 46]. In this study, the effect of D. sephen venom on reduced glutathione levels in HeLa cancer cells was examined. The treatment with venom (4, 8, 12, and 16 μg/mL) decreased GSH levels in HeLa cells. Among all the doses tested, 16 μg/mL significantly decreased GSH levels in HeLa cells. The resistance in most cases is associated with higher GSH levels within these cancer cells. Thus, approaches to cancer treatment could potentially benefit from a selective GSH depleting strategy [47]. Therefore, our results indicate that the prominent decrease of GSH levels in cancer cells treated with D. sephen venom, and further purification of its active constituents could lead to a novel drug candidate.

Conclusions

The present findings suggest that D. sephen venom initiates cancer cell death by decreasing cell proliferation, antioxidant status and mitochondrial membrane potential; and by increasing intracellular ROS, lipid peroxidation and apoptosis in human cervical (HeLa) cancer cells. The current results clearly demonstrate the involvement of an oxidative mechanism for the antiproliferative effect of D. sephen venom on HeLa cells. Thus, marine stingray venoms could be used as a source of antiproliferative agents after further purification in the future.

References

  1. de Vries DJ, Beart PM. Fishing for drugs from the sea: status and strategies. Trends Pharmacol Sci. 1995;16(8):275–9.

    Article  PubMed  Google Scholar 

  2. Aneiros A, Garateix A. Bioactive peptides from marine sources: pharmacological properties and isolation procedures. J Chromatogr B Anal Technol Biomed Life Sci. 2004;803(1):41–53.

    Article  CAS  Google Scholar 

  3. Bhakuni DS. Some aspects of bioactive marine natural products. J Indian Chem Soc. 1998;75:191–205.

    CAS  Google Scholar 

  4. Weinstein IB. Disorders in cell circuitry during multistage carcinogenesis: the role of homeostasis. Carcinogenesis. 2000;21(5):857–64.

    Article  CAS  PubMed  Google Scholar 

  5. Kim MS, Kang HJ, Moon A. Inhibition of invasion and induction of apoptosis by curcumin in H-ras-transformed MCF10A human breast epithelial cells. Arch Pharm Res. 2001;24(4):349–54.

    Article  CAS  PubMed  Google Scholar 

  6. Calmette A, Saenz A, Costil L. Effets du venin de cobra sur les greffes cancereuses et sur le cancer spontane (adenocarcinoma) de la souris. CR Acad Sci. 1933;197:205–9.

    Google Scholar 

  7. Orsolic N, Sver L, Vestovsek S, Terzic S. Inhibition of mammary carcinoma cell proliferation in vitro and tumor growth in vivo by bee venom. Toxicon. 2003;41(7):861–70.

    Article  CAS  PubMed  Google Scholar 

  8. Wang WX, Ji YH. Scorpion venom induces glioma cell apoptosis in vivo and inhibits glioma tumor growth in vitro. J Neurooncol. 2005;75(1):1–7.

    Article  Google Scholar 

  9. Gupta SD, Gomes A, Debnath A, Saha A, Gomes A. Apoptosis induction in human leukemic cells by a novel protein Bengalin, isolated from Indian black scorpion venom: through mitochondrial pathway and inhibition of heat shock proteins. Chem Biol Interact. 2003;183(2):293–303.

    Article  CAS  Google Scholar 

  10. Mayer AM, Glaser KB, Cuevas C, Jacobs RS, Kem W, Little RD, et al. The odyssey of marine pharmaceuticals: a current pipeline perspective. Trends Pharmacol Sci. 2010;31(6):255–65.

    Article  CAS  PubMed  Google Scholar 

  11. Blunt JW, Copp BR, Keyzers RA, Munro MH, Prinsep MR. Marine natural products. Nat Prod Rep. 2013;30(2):237–323.

    Article  CAS  PubMed  Google Scholar 

  12. Junghanss T, Bodio M. Medically important venomous animals: biology, prevention, first aid, and clinical management. Clin Infect Dis. 2006;43(10):1309–17.

    Article  PubMed  Google Scholar 

  13. Fenner PJ, Williamson JA, Skinner RA. Fatal and non-fatal stingray envenomation. Med J Aust. 1989;151(11–12):621–5.

    Article  CAS  PubMed  Google Scholar 

  14. Conceição K, Konno K, Melo RL, Marques EE, Hiruma-Lima CA, Lima C, et al. Orpotrin: a novel vasoconstrictor peptide from the venom of the Brazilian stingray Potamotrygon gr. orbignyi. Peptides. 2006;27(12):3039–46.

    Article  PubMed  CAS  Google Scholar 

  15. Conceição K, Santos JM, Bruni FM, Klitzke CF, Marques EE, Borges MH, et al. Characterization of a new bioactive peptide from Potamotrygon gr. Orbignyi freshwater stingray venom. Peptides. 2009;30(12):2191–9.

    Article  PubMed  CAS  Google Scholar 

  16. Lalwani K. Animal toxins: scorpaenidae and stingrays. Br J Anaesth. 1995;75(2):247.

    Article  CAS  PubMed  Google Scholar 

  17. Weiss BF, Wolfenden DH. Survivor of a stingray injury to the heart. Med J Aust. 2001;175(1):33–4.

    Article  CAS  PubMed  Google Scholar 

  18. Kumar KR, Vennila R, Kanchana S, Arumugam M, Balasubramaniam T. Fibrinogenolytic and anticoagulant activities in the tissue covering the stingers of marine stingrays Dasyatis sephen and Aetobatis narinari. J Thromb Thrombolysis. 2011;31:464–71.

    Article  PubMed  CAS  Google Scholar 

  19. Haddad Junior V, Neto GD, de Paula Neto JB, de Luna Marques FP, Barbaro CK. Freshwater stingrays: study of epidemiologic, clinic and therapeutic aspects based on 84 envenomings in humans and some enzymatic activities of the venom. Toxicon. 2004;43(3):287–94.

    Article  CAS  Google Scholar 

  20. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J Immunol Method. 1983;65(1–2):55–63.

    Article  CAS  Google Scholar 

  21. Karthikeyan S, Prasad NR, Ganamani A, Balamurugan E. Anticancer activity of resveratrol-loaded gelatin nanoparticles on NCI-H460 non-small cell lung cancer cells. Biomed Prev Nutr. 2013;3(1):64–73.

    Article  Google Scholar 

  22. Niehaus Jr WG, Samuelsson B. Formation of malonaldehyde from phospholipid arachidonate during microsomal lipid peroxidation. Eur J Biochem. 1968;6(1):126–30.

    Article  CAS  PubMed  Google Scholar 

  23. Klein RA. The detection of oxidation in liposome preparations. Biochem Biophys Acta. 1970;210(3):486–9.

    Article  CAS  PubMed  Google Scholar 

  24. Jiang ZY, Hunt JV, Wolff SP. Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein. Anal Biochem. 1992;202(2):384–9.

    Article  CAS  PubMed  Google Scholar 

  25. Kakkar ZYP, Das B, Viswanathan PN. A modified spectrophotometric assay of superoxide dismutase (SOD). Indian J Biochem Biophys. 1984;21(2):130–2.

    CAS  PubMed  Google Scholar 

  26. Sinha KA. Colorimetric assay of catalase. Anal Biochem. 1972;47(2):389–94.

    Article  CAS  PubMed  Google Scholar 

  27. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG. Selenium: biochemical role as a component of glutathione peroxidase. Science. 1973;179(4073):588–90.

    Article  CAS  PubMed  Google Scholar 

  28. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959;82(1):70–7.

    Article  CAS  PubMed  Google Scholar 

  29. Mignotte B, Vayssiere JL. Mitochondria and apoptosis. Eur J Biochem. 1998;252(1):1–15.

    Article  CAS  PubMed  Google Scholar 

  30. Satoh F, Nakagawa H, Yamada H, Nagasaka K, Nagasaka T, Araki Y, et al. Fishing for bioactive substances from scorpionfish and some sea urchins. J Nat Toxins. 2002;11(4):297–304.

    CAS  PubMed  Google Scholar 

  31. Balasubashini MS, Karthigayan S, Somasundaram ST, Balasubramanian T, Viswanathan P, Menon VP. In vivo and in vitro characterization of the biochemical and pathological changes induced by lionfish [Pterois volitans] venom in mice. Toxicol Mech Methods. 2006;16(9):525–31.

    Article  CAS  PubMed  Google Scholar 

  32. Fleury C, Mignotte B, Vayssiére JL. Mitochondrial reactive oxygen species in cell death signaling. Biochimie. 2002;84(2–3):131–41.

    Article  CAS  PubMed  Google Scholar 

  33. Martindale JL, Holbrook NJ. Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol. 2002;192(1):1–15.

    Article  CAS  PubMed  Google Scholar 

  34. Sun LK, Yoshii Y, Hyodo A, Tsurushima H, Saito A, Harakuni T, et al. Apoptotic effect in the glioma cells induced by specific protein extracted from Okinawa Habu (Trimeresurus flavoviridis) venom in relation to oxidative stress. Toxicol in Vitro. 2003;17(2):169–77.

    Article  CAS  PubMed  Google Scholar 

  35. Prasad NR, Karthikeyan A, Karthikeyan S, Reddy BV. Inhibitory effect of caffeic acid on cancer cell proliferation by oxidative mechanism in human HT-1080 fibrosarcoma cell line. Mol Cell Biochem. 2011;349(1–2):11–9.

    Article  CAS  Google Scholar 

  36. Hildeman DA, Mitchell T, Teague TK, Henson P, Day BJ, Kappler J, et al. Reactive oxygen species regulate activation-induced T cell apoptosis. Immunity. 1999;10(6):735–44.

    Article  CAS  PubMed  Google Scholar 

  37. Chou DA, Kuo YH, Jan MS, Chang YY, Chen YC, Chiu HL, et al. Caffeate derivatives induce apoptosis in COLO 205 human colorectal carcinoma cells through Fas- and mitochondria-mediated pathways. Food Chem. 2012;131:1460–5.

    Article  CAS  Google Scholar 

  38. Zargan J, Sajad S, Umar M, Naime M, Ali S, Khan HA. Scorpion (Odontobuthus doriae) venom induces apoptosis and inhibits DNA synthesis in human neuroblastoma cells. Mol Cell Biochem. 2011;348(1–2):173–81.

    Article  CAS  PubMed  Google Scholar 

  39. Zhang L, Li H, Wu WT. Purification and characterization of cytotoxins from Agkistrodon acutus venom and their anticancer activity. J Chin Pharm Sci. 2004;13(2):97–102.

    Google Scholar 

  40. Belloc F, Dumain P, Boisseau MR, Jalloustre C, Reiffers J, Bernard P, et al. A flow cytometric method using Hoecht 33342 and propidium Iodide for simultaneous analysis and apoptosis determination in unfixed cells. Cytometry. 1994;17:59–65.

    Article  CAS  PubMed  Google Scholar 

  41. Polidoro G, Di Ilio C, Arduini A, La Rovere G, Federici G. Superoxide dismutase, reduced glutathione and TBA-reactive products in erythrocytes of patients with multiple sclerosis. Int J Biochem. 1984;16(5):505–10.

    Article  CAS  PubMed  Google Scholar 

  42. Matés JM, Sánchez-Jiménez FM. Role of reactive oxygen species in apoptosis: implications for cancer therapy. Int J Biochem Cell Biol. 2000;32(2):157–70.

    Article  PubMed  Google Scholar 

  43. Abdel-Rahman MA, Abdel-Nabi IM, El-Naggar MS, Abbas OA, Strong PN. Conus vexillum venom induces oxidative stress in Ehrlich’s ascites carcinoma cells: an insight into the mechanism of induction. J Venomous Anim Toxins Incl Trop Dis. 2013;19(1):10.

    Article  Google Scholar 

  44. Sergediene E, Jonsson K, Szymusiak H, Tyrakowska B, Rietjens IM, Cenas N. Prooxidant toxicity of polyphenolic antioxidants to HL-60 cells: description of quantitative structure activity relationships. FEBS Lett. 1999;462(3):392–6.

    Article  CAS  PubMed  Google Scholar 

  45. Estrela JM, Ortega A, Obrador E. Glutathione in cancer biology and therapy. Crit Rev Clin Lab Sci. 2006;43(2):143–481.

    Article  CAS  PubMed  Google Scholar 

  46. Ortega AL, Carretero J, Obrador E, Gambini J, Asensi M, Rodilla V, et al. Tumor cytotoxicity by endothelial cells. Impairment of the mitochondrial system for glutathione uptake in mouse B16 melanoma cells that survive after in vitro interaction with the hepatic sinusoidal endothelium. J Biol Chem. 2003;278(16):13888–97.

    Article  CAS  PubMed  Google Scholar 

  47. Vad NM, Yount G, Moore D, Weidanz J, Moridani MY. Biochemical mechanism of acetaminophen (APAP) induced toxicity in melanoma cell lines. J Pharm Sci. 2009;98(4):1409–25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ocular Pharmacology and Pharmacy, Centre for Ophthalmic Sciences, All India Institute of Medical Sciences (AIIMS), New Delhi, India

    RK Rajeshkumar & T Velpandian

  2. Center of Advanced Study in Marine Biology, Annamalai University, Parangipettai, Tamil Nadu, India

    RK Rajeshkumar, R Vennila, M Arumugam & T Balasubramaniam

  3. Department of Biochemistry and Biotechnology, Annamalai University, Tamil Nadu, India

    S Karthikeyan & N Rajendra Prasad

Authors
  1. RK Rajeshkumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R Vennila
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S Karthikeyan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N Rajendra Prasad
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M Arumugam
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. T Velpandian
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. T Balasubramaniam
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to RK Rajeshkumar.

Additional information

Competing interests

The authors declare that there are no competing interests.

Authors’ contributions

RK, SK, MA, NR, RV contributed in the design, execution of the study and interpretation of the data, TB and TV contributed intellectually in the preparation of this manuscript.

An erratum to this article is available online at https://doi.org/10.1590/s40409-015-0036-5er.

Additional file

Additional file 1:

Scientific classification and image ofD. sephen. (DOCX 105 kb)

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rajeshkumar, R., Vennila, R., Karthikeyan, S. et al. Antiproliferative activity of marine stingray Dasyatis sephen venom on human cervical carcinoma cell line. J Venom Anim Toxins Incl Trop Dis 21, 41 (2015). https://doi.org/10.1186/s40409-015-0036-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s40409-015-0036-5

Keywords

Journal of Venomous Animals and Toxins including Tropical Diseases

ISSN: 1678-9199

Contact us